Carlos Serra Traynor

机构：AstraZeneca (Spain) · ORCID：0000-0002-3753-7552

发表论文 5 篇 · 总被引 15 次 · h-index 3

代表论文

• Longitudinal Circulating Tumor DNA Modeling to Predict Disease Progression in First‐Line Mutant Epidermal Growth Factor Receptor Non‐Small Cell Lung Cancer (2023 · Clinical Pharmacology & Therapeutics · 被引 9)
• Abstract 1765: Discovery and first disclosure of AZD8205, a B7-H4-targeted antibody-drug conjugate utilizing a novel topoisomerase I linker-warhead (2022 · Cancer Research · 被引 3)
• Imputing Biomarker Status from RWE Datasets—A Comparative Study (2021 · Journal of Personalized Medicine · 被引 3)
• Stochastic Gates for Covariate Selection in Population Pharmacokinetics Modeling (2026 · CPT Pharmacometrics & Systems Pharmacology)
• Stochastic gates for covariate selection in population pharmacokinetics modelling (2025 · bioRxiv (Cold Spring Harbor Laboratory))